Nerve injury-induced protein-1 (Ninjurin-1, Ninj1) was initially identified as a novel adhesion molecule in rat sciatic nerve and to be up-regulated in neurons and Schwann cells of distal nerve segments after nerve transection or crush injury. Recently, Ninj1 was found to act as a modulator of cell migration, angiogenesis, and apoptosis. Accumulating evidence indicates that innate immune response plays beneficial and deleterious roles in brain ischemia, and the trans-endothelial migration of blood-derived immune cells is key initiator of this response. In the present study, we examined the expression profile and cellular distribution of Ninj1 in rat brain after transient focal cerebral ischemia. Ninj1 expression was found to be significantly induced in cortical penumbras 1 day after 60 min of middle cerebral artery occlusion (MCAO) and to increase gradually for 8 days and then declined. In infarction cores of cortices, patterns of Ninj1 expression were similar to those observed in cortical penumbras, except induction was maintained for 10 days. At 1 day post-MCAO, Ninj1 inductions were detected mainly in neutrophils and endothelial cells in both infarction cores and penumbras, but reactive macrophages were the major cellular expressers of Ninj1 at 4 days post-MCAO. Expressional induction in reactive macrophages was maintained in infarction cores after 12 days post-MCAO but not in penumbras. These dynamic expressions of Ninj1 in different immune cells at different times suggest that this protein performs various, critical roles in the modulation of acute and delayed immune responses in the postischemic brain.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844564 | PMC |
| http://dx.doi.org/10.5607/en.2016.25.2.64 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Critical Care Decisions After Large Core Cerebral Infarctions: A Secondary Analysis From the SELECT2 Trial.
Ann Neurol
December 2024
Department of Neurology and Stroke, University Hospital Cleveland Medical Center, Case Western Reserve University, Cleveland, OH.
Article Synopsis
- This study analyzed decisions regarding decompressive hemicraniectomy (DHC) and early withdrawal of life-sustaining therapy (WLST) in patients with large vessel occlusion (LVO) and large ischemic strokes from the SELECT2 trial.* -
- Among 352 patients, DHC was utilized in 55 patients, and WLST was chosen for 81, showing no significant differences in usage between those receiving endovascular thrombectomy (EVT) and those treated medically.* -
- About 21% of DHC patients were able to walk independently after one year, indicating that DHC did not negatively impact the benefits of thrombectomy, while WLST generally resulted in poor outcomes.*
Cost-Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke.
Ann Neurol
October 2024
Department of Neurology, University Hospital Cleveland Medical Center - Case Western Reserve University, Cleveland, OH.
Article Synopsis
- Endovascular thrombectomy (EVT) is shown to be cost-effective for patients with extensive ischemic injury, providing better health outcomes and lower societal costs compared to standard care among various populations, including those in the US, Australia, and Spain.
- The analysis utilized a Markov model to assess outcomes based on quality-adjusted life years (QALYs) and found significant cost savings, with reductions of $23,409 in the US, $10,691 in Australia, and $30,036 in Spain.
- EVT remains cost-effective across different age groups and severity levels of strokes, indicating a need to adapt healthcare systems to increase thrombectomy access for patients with larger strokes.
Predicting Futile Recanalization After Endovascular Thrombectomy for Patients With Stroke With Large Cores: The SNAP Score.
Neurosurgery
October 2024
Department of Neurosurgery, Division of Neuroendovascular Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Article Synopsis
- Researchers aimed to create and validate a prediction score for futile recanalization (FR) in patients with low Alberta Stroke Program Early Computed Tomography Scores (ASPECTS) who underwent endovascular thrombectomy (EVT) for large vessel occlusions (LVO).
- The study analyzed data from 219 patients with anterior circulation LVO and identified key predictors of FR, resulting in the development of the SNAP score, which considers factors like the site of occlusion and patient age.
- The SNAP score successfully predicted FR with an area under the curve of 0.79 in both training and validation cohorts, indicating its potential usefulness for guiding expectations in patients undergoing EVT for severe strokes.
Endovascular thrombectomy after anterior circulation large vessel ischemic stroke: an updated meta-analysis.
Syst Rev
October 2024
Neuroscience Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
Article Synopsis
- Endovascular thrombectomy (EVT) combined with medical treatment (MT) significantly improves disability and functional outcomes in patients with large-vessel occlusions compared to MT alone, based on a systematic review of 15 randomized clinical trials involving 3897 patients.
- The study found higher rates of functional independence, excellent outcomes, and recanalization with the EVT plus MT approach, while safety outcomes were generally comparable, except for a higher risk of certain types of hemorrhage with EVT.
- The findings suggest that EVT plus MT should be considered the standard care for acute ischemic stroke patients with large-vessel occlusions, although careful patient selection is crucial due to safety concerns.
Best Medical Therapy for Asymptomatic Carotid Stenosis: Imminent or Ineffective?
Ann Vasc Surg
September 2024
Division of Vascular and Endovascular Surgery, Department of Surgery, Zucker School of Medicine at Hofstra, Northwell Health, New Hyde Park, NY. Electronic address:
Article Synopsis
- * New advancements in medical therapy and carotid artery stenting (CAS) have led to questions about the effectiveness of CEA compared to BMT alone, showing little difference in outcomes and highlighting the importance of identifying high-risk plaques.
- * Ongoing studies, especially the CREST-2 trial, are focusing on optimizing treatment for asymptomatic carotid stenosis, stressing adherence to modern BMT and lifestyle modifications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!